Concepedia

Charles Knirsch

CK

40

Publications

3.8K

Citations

32

H-Index

1996

Active since

Affiliations

Pfizer (United States)(Current)

Columbia University

New York City Department of Health and Mental Hygiene

Columbia University Irving Medical Center

Armed Forces Research Institute of Medical Science

Charles Knirsch is an author at Pfizer (United States) specializing in medicine, antimicrobial resistance, and antibiotics.

ORCID

Top concepts

Publications per year

1996–2019

40

Publications

40

Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections

John A. Weigelt, Kamal Itani, Dennis L. Stevens et al. · Antimicrobial Agents and Chemotherapy · 2005 · 450 citations · Full text

Azithromycin for the Secondary Prevention of Coronary Events

J. Thomas Grayston, Richard A. Kronmal, Lisa A. Jackson et al. · New England Journal of Medicine · 2005 · 374 citations · Full text

Nonadherence in Tuberculosis Treatment: Predictors and Consequences in New York City

Ariel Pablos-Méndez, Charles Knirsch, R. Graham Barr et al. · The American Journal of Medicine · 1997 · 252 citations · Full text

Complicated Skin and Skin‐Structure Infections and Catheter‐Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study

Mark H. Wilcox, Kenneth J. Tack, Emilio Bouza et al. · Clinical Infectious Diseases · 2008 · 216 citations

The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics.

Ariel Pablos-Méndez, Jeffrey Blustein, Charles Knirsch · American Journal of Public Health · 1997 · 192 citations · Full text

Rows per page

1–5 of 40